Related references
Note: Only part of the references are listed.Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: Potential mechanism for uremic vascular calcification
K. A. Lomashvili et al.
KIDNEY INTERNATIONAL (2008)
The fallacy of the calcium-phosphorus product
W. C. O'Neill
KIDNEY INTERNATIONAL (2007)
Vascular calcification and cardiovascular function in chronic kidney disease
M Sigrist et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
GA Block et al.
KIDNEY INTERNATIONAL (2005)
Reduced plasma pyrophosphate levels in hemodialysis patients
KA Lomashvili et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Phosphate-induced vascular calcification: Role of pyrophosphate and osteopontin
KA Lomashvili et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Determinants of progressive vascular calcification in haemodialysis patients
GM Chertow et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
GM Chertow et al.
KIDNEY INTERNATIONAL (2002)
Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease
J Blacher et al.
HYPERTENSION (2001)
PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification
F Rutsch et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Apoptosis may determine the release of skeletal alkaline phosphatase activity from human osteoblast-line cells
JR Farley et al.
CALCIFIED TISSUE INTERNATIONAL (2001)